With regard to the government's Substance Use and Addictions Program and the funding of London InterCommunity Health Centre (LIHC) program: (a) what criteria has the government established to measure the success of the LIHC program, and are these success criteria being met; (b) how frequently does the government receive updates or reports from the LIHC regarding its performance and success in meeting the specified criteria; (c) what is the government’s explanation for why the number of overdoses increased following the implementation of the program; (d) what is the government’s explanation for why opioid-related deaths and hospitalizations are greater in the Middlesex—London area compared to the rest of Ontario; (e) is the government studying or assessing the diversion of drugs from the LIHC program; (f) what measures are being taken to prevent the diversion of drugs from the LIHC program; and (g) how is the government educating the public about the harms of diversion?
In the House of Commons on January 29th, 2024. See this statement in context.